| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |